O'Melveny&Myers

    | BY

    clpstaff &clp articles

    O'Melveny & Myers represented Charles River Laboratories International in the formation of Charles River Laboratories Preclinical Services ­ China. The…

    O'Melveny & Myers represented Charles River Laboratories International in the formation of Charles River Laboratories Preclinical Services ­ China. The joint venture was formed with Shanghai BioExplorer, a Shanghai, China-based provider of preclinical services, and will be majority-owned and controlled by Charles River. The transaction is subject to regulatory approval, and is expected to close by the end of the second quarter of 2007.

    This premium content is reserved for
    China Law & Practice Subscribers.

    • A database of over 3,000 essential documents including key PRC legislation translated into English
    • A choice of newsletters to alert you to changes affecting your business including sector specific updates
    • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
    For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]